Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Bisphosphonates in orthopaedic surgery.

Morris CD, Einhorn TA.

J Bone Joint Surg Am. 2005 Jul;87(7):1609-18. Review.

PMID:
15995133
2.

Treatment of bone diseases with bisphosphonates, excluding osteoporosis.

Devogelaer JP.

Curr Opin Rheumatol. 2000 Jul;12(4):331-5. Review.

PMID:
10910187
3.

[The use of bisphosphonates for treating pathological states in orthopedics].

Białecki P, Bohatyrewicz A, Machoy-Mokrzyńska A, Białecka M.

Chir Narzadow Ruchu Ortop Pol. 2008 Jul-Aug;73(4):266-73. Review. Polish.

PMID:
18847019
4.

Bisphosphonates: pharmacology and effects on the growing skeleton.

Papapoulos SE.

Acta Univ Carol Med (Praha). 1994;40(1-4):29-32. Review. No abstract available.

PMID:
9355668
5.

The pharmacology and therapeutic utility of bisphosphonates.

Lourwood DL.

Pharmacotherapy. 1998 Jul-Aug;18(4):779-89. Review.

PMID:
9692651
6.

Bisphosphonates: mode of action and pharmacology.

Russell RG.

Pediatrics. 2007 Mar;119 Suppl 2:S150-62. Review.

PMID:
17332236
7.

[Bisphosphonates: indications in bone diseases other than osteoporosis].

Abdelmoula LC, Ben M'barek R, Ben Hadj Yahia C, Tekaya R, Testouri N, Chaabouni L, Zouari R.

Tunis Med. 2011 Jun;89(6):511-6. Review. French.

8.

Bisphosphonate treatment of pediatric bone disease.

Speiser PW, Clarson CL, Eugster EA, Kemp SF, Radovick S, Rogol AD, Wilson TA; LWPES Pharmacy and Therapeutic Committee.

Pediatr Endocrinol Rev. 2005 Dec;3(2):87-96. Review.

PMID:
16361982
9.

Bisphosphonates: from grandparents to grandchildren.

Srivastava T, Alon US.

Clin Pediatr (Phila). 1999 Dec;38(12):687-702. Review.

PMID:
10618761
10.

[Bisphosphonates in pharmacotherapy of bone diseases].

Iur'ieva EA, Matkovskaia TA, Elagina IA, Stoliarov IuIu.

Eksp Klin Farmakol. 2000 May-Jun;63(3):74-9. Review. Russian.

PMID:
10934603
11.

Bisphosphonate treatment of bone disease.

Shaw NJ, Bishop NJ.

Arch Dis Child. 2005 May;90(5):494-9. Review.

12.

Cellular and molecular mechanisms of action of bisphosphonates.

Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC.

Cancer. 2000 Jun 15;88(12 Suppl):2961-78. Review.

PMID:
10898340
13.

Bisphosphonates: effects on osteoblast.

Maruotti N, Corrado A, Neve A, Cantatore FP.

Eur J Clin Pharmacol. 2012 Jul;68(7):1013-8. doi: 10.1007/s00228-012-1216-7. Epub 2012 Feb 9. Review.

PMID:
22318756
14.

Pharmacological diversity among drugs that inhibit bone resorption.

Russell RG.

Curr Opin Pharmacol. 2015 Jun;22:115-30. doi: 10.1016/j.coph.2015.05.005. Epub 2015 Jun 3. Review.

PMID:
26048735
15.

Bisphosphonates in bone diseases other than osteoporosis.

Orcel P, Beaudreuil J.

Joint Bone Spine. 2002 Jan;69(1):19-27. Review.

PMID:
11858352
16.

Bisphosphonates: pharmacology, mechanisms of action and clinical uses.

Russell RG, Croucher PI, Rogers MJ.

Osteoporos Int. 1999;9 Suppl 2:S66-80. Review. No abstract available.

PMID:
10525729
17.

Discovery, clinical development, and therapeutic uses of bisphosphonates.

Licata AA.

Ann Pharmacother. 2005 Apr;39(4):668-77. Epub 2005 Mar 8. Review.

PMID:
15755793
18.

Bisphosphonate therapeutics in bone disease: the hard and soft data on osteoclast inhibition.

Drake MT, Cremers SC.

Mol Interv. 2010 Jun;10(3):141-52. doi: 10.1124/mi.10.3.5. Review.

PMID:
20539033
19.

Mechanisms of action of bisphosphonates.

Breuil V.

Rev Rhum Engl Ed. 1999 Jun;66(6):339-43. Review. No abstract available.

PMID:
10418063
20.

Clinical effects of bisphosphonates in involutional osteoporosis.

Ott SM.

J Bone Miner Res. 1993 Dec;8 Suppl 2:S597-606. Review.

PMID:
8122531

Supplemental Content

Support Center